The ceramide ratio: A predictor of cardiometabolic risk                         1

Trevor S. Tippetts; William L. Holland; Scott A. Summers

doi:10.1194/jlr.C088377

The ceramide ratio: A predictor of cardiometabolic risk ¹

Trevor S. Tippetts, William L. Holland, Scott A. Summers

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1549-1550
Number of pages	2
Journal	Journal of lipid research
Volume	59
Issue number	9
DOIs	https://doi.org/10.1194/jlr.C088377
State	Published - 2018

ASJC Scopus subject areas

Biochemistry
Endocrinology
Cell Biology

Access to Document

10.1194/jlr.C088377

Cite this

@article{c5e0ba2691aa47ce9a737a39bd24c0b3,

title = "The ceramide ratio: A predictor of cardiometabolic risk 1",

author = "Tippetts, {Trevor S.} and Holland, {William L.} and Summers, {Scott A.}",

note = "Funding Information: The authors receive research support from the National Institutes of Health (DK112826 and DK108833 to W.L.H. and DK115824 to S.A.S.), the Juvenile Diabetes Research Foundation (to W.L.H.), the American Diabetes Association (to S.A.S.), the American Heart Association (to S.A.S.), and the Huntsman Cancer Institute (to S.A.S.). We disclose that Scott Summers is a consultant and shareholder for Centaurus Therapeutics. DOI https://doi.org/10.1194/jlr.C088377 Funding Information: The authors receive research support from the National Institutes of Health (DK112826 and DK108833 to W.L.H. and DK115824 to S.A.S.), the Juvenile Diabetes Research Foundation (to W.L.H.), the American Diabetes Association (to S.A.S.), the American Heart Association (to S.A.S.), and the Huntsman Cancer Institute (to S.A.S.). We disclose that Scott Summers is a consultant and shareholder for Centaurus Therapeutics.",

year = "2018",

doi = "10.1194/jlr.C088377",

language = "English (US)",

volume = "59",

pages = "1549--1550",

journal = "Journal of Lipid Research",

issn = "0022-2275",

publisher = "American Society for Biochemistry and Molecular Biology Inc.",

number = "9",

}

TY - JOUR

T1 - The ceramide ratio

T2 - A predictor of cardiometabolic risk 1

AU - Tippetts, Trevor S.

AU - Holland, William L.

AU - Summers, Scott A.

N1 - Funding Information: The authors receive research support from the National Institutes of Health (DK112826 and DK108833 to W.L.H. and DK115824 to S.A.S.), the Juvenile Diabetes Research Foundation (to W.L.H.), the American Diabetes Association (to S.A.S.), the American Heart Association (to S.A.S.), and the Huntsman Cancer Institute (to S.A.S.). We disclose that Scott Summers is a consultant and shareholder for Centaurus Therapeutics. DOI https://doi.org/10.1194/jlr.C088377 Funding Information: The authors receive research support from the National Institutes of Health (DK112826 and DK108833 to W.L.H. and DK115824 to S.A.S.), the Juvenile Diabetes Research Foundation (to W.L.H.), the American Diabetes Association (to S.A.S.), the American Heart Association (to S.A.S.), and the Huntsman Cancer Institute (to S.A.S.). We disclose that Scott Summers is a consultant and shareholder for Centaurus Therapeutics.

PY - 2018

Y1 - 2018

UR - http://www.scopus.com/inward/record.url?scp=85052654078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052654078&partnerID=8YFLogxK

U2 - 10.1194/jlr.C088377

DO - 10.1194/jlr.C088377

M3 - Comment/debate

C2 - 29987126

AN - SCOPUS:85052654078

SN - 0022-2275

VL - 59

SP - 1549

EP - 1550

JO - Journal of Lipid Research

JF - Journal of Lipid Research

IS - 9

ER -

The ceramide ratio: A predictor of cardiometabolic risk 1

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

The ceramide ratio: A predictor of cardiometabolic risk ¹